Evidence map›Paper›PMID 36812520›Full record

ArticlePLOS digital health2022

A distributed approach to the regulation of clinical AI.

Trishan Panch, Erin Duralde, Heather Mattie, Gopal Kotecha, Leo Anthony Celi, Melanie Wright, Felix Greaves

Abstract read
In one paragraph

Article in PLOS digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Equity and AI governance at academic medical centers.The American journal of managed care · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Trishan PanchDivision of Health Policy and Management, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-6554-061X
Erin DuraldePopulation Health Management, Mass General Brigham, Somerville, Massachusetts.ORCID https://orcid.org/0000-0002-5447-7846
Heather MattieDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-1263-2537
Gopal KotechaDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-6768-1221
Leo Anthony CeliDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.ORCID https://orcid.org/0000-0001-6712-6626
Melanie WrightCollege of Pharmacy, Idaho State University, Meridian, Idaho.ORCID https://orcid.org/0000-0001-7121-504X
Felix GreavesNational Institute for Health and Care Excellence, London, United Kingdom.

Funding

Critical Care Informatics: Ethical considerations around the use and sharing of health-related dataR01EB017205 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CELI, LEO ANTHONY G, MARK, ROGER GREENWOOD · 2014 to 2021
$3.8M
NIBIB NIH HHS R01 EB017205
6 · The paper itself

Abstract

Regulation is necessary to ensure the safety, efficacy and equitable impact of clinical artificial intelligence (AI). The number of applications of clinical AI is increasing, which, amplified by the need for adaptations to account for the heterogeneity of local health systems and inevitable data drift, creates a fundamental challenge for regulators. Our opinion is that, at scale, the incumbent model of centralized regulation of clinical AI will not ensure the safety, efficacy, and equity of implemented systems. We propose a hybrid model of regulation, where centralized regulation would only be required for applications of clinical AI where the inference is entirely automated without clinician review, have a high potential to negatively impact the health of patients and for algorithms that are to be applied at national scale by design. This amalgam of centralized and decentralized regulation we refer to as a distributed approach to the regulation of clinical AI and highlight the benefits as well as the pre-requisites and challenges involved.

Identifiers

PMID36812520
PMCPMC9931237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.